Valneva SE Cash Flow from Operating Activities 2021-2024 | VALN
Valneva SE Annual Cash Flow Ops (Millions of US $) |
|
---|---|
2024 | $-73 |
2023 | $-219 |
2022 | $-258 |
2021 | $91 |
2020 | $157 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | MED PRODUCTS | $0.549B | $0.184B |
Valneva SE is a specialty vaccine company. It is focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. Valneva SE is based in Saint-Herblain, France. |